SCHEMBL3295174

SCHEMBL3295174

CN1CCN(c2cccc3c2cc(C(N)=O)n3Cc2ccccc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.49
PLA2G10 O15496 1/20 0.47
HTR6 P50406 3/20 0.44
DRD2 P14416 2/20 0.44
CCR2 P41597 2/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
HSD17B10 Q99714 2/20 0.43
HTR1A P08908 3/20 0.42
HTR2A P28223 1/20 0.42
GAA P10253 2/20 0.42
USP2 O75604 1/20 0.42
NOD2 Q9HC29 1/20 0.42
CHRM2 P08172 1/20 0.42
ADRA2A P08913 1/20 0.42
CHRM1 P11229 1/20 0.42
DRD1 P21728 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
ADRA1A P35348 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3300361 0.91 CCR2 (0.52) HTR6DRD2CCR2KDM4EALDH1A1
SCHEMBL3297730 0.87 HTR6 (0.56) F10PLA2G10HTR6CCR2KDM4E
SCHEMBL14193779 0.86 F10 (0.49) F10PLA2G10HTR6DRD2CCR2
Hydrochloric Acid SCHEMBL3304362 0.86 HTR6 (0.55) F10PLA2G10HTR6CCR2KDM4E
SCHEMBL3298363 0.85 F10 (0.48) F10KDM4EALDH1A1HTR1AHTR2A
SCHEMBL3296638 0.81 F10 (0.48) F10PLA2G10HTR6DRD2CCR2
Hydrochloric Acid SCHEMBL3300923 0.81 TOP1 (0.45) F10PLA2G10
SCHEMBL3296433 0.79 HTR6 (0.60) F10HTR6DRD2CCR2KDM4E
Hydrochloric Acid SCHEMBL3297278 0.78 HTR6 (0.59) F10HTR6DRD2CCR2KDM4E
SCHEMBL3299174 0.78 HTR3A (0.47) F10HTR6DRD2CCR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741326-B2 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands ROCHE PALO ALTO LLC (US) 2010-06-22 US disclosed
US-7741326-B2 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands ROCHE PALO ALTO LLC (US) 2010-06-22 US disclosed
US-7741326-B2 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands ROCHE PALO ALTO LLC (US) 2010-06-22 US disclosed
EP-2084131-A1 INDOLE AND BENZOFURAN 2-CARBOXAMIDE DERIVATIVES F. Hoffmann-Roche AG (CH) 2009-08-05 EP disclosed
US-20080146587-A1 Indole and benzofuran 2-carboxamide derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed
US-20080146587-A1 Indole and benzofuran 2-carboxamide derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed
US-20080146587-A1 Indole and benzofuran 2-carboxamide derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed
WO-2008055808-A1 INDOLE AND BENZOFURAN 2-CARBOXAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-05-15 WO disclosed
WO-2008055808-A1 INDOLE AND BENZOFURAN 2-CARBOXAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146587-A1 Indole and benzofuran 2-carboxamide derivatives and uses thereof AR, CNR2, CNR1 F10 2671/4885PLA2G10 3984/4885HTR6 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.